Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXIV. Cytotoxic treatment is an additional risk factor for the development of symptomatic osteonecrosis in lupus patients: results of a nested matched case-control study.
about
Validity of a self-administered version of the brief index of lupus damage in a predominantly African American systemic lupus erythematosus cohort.The epidemiology of osteonecrosis: findings from the GPRD and THIN databases in the UKRisk factors for osteonecrosis of the jaws: a case-control study from the CONDOR dental PBRNOsteonecrosis in systemic lupus erythematosus: an early, frequent, and not always symptomatic complicationMultifocal osteonecrosis in systemic lupus erythematosus: case report and review of the literatureUpdates on bisphosphonates and potential pathobiology of bisphosphonate-induced jaw osteonecrosis.The role of antimalarial agents in the treatment of SLE and lupus nephritis.Utilizing registries in systemic lupus erythematosus clinical research.Time trend and risk factors of avascular bone necrosis in patients with systemic lupus erythematosus.The evolving concept of SLE comorbidities.High triglyceride is a risk factor for silent osteonecrosis of the femoral head in systemic lupus erythematosus.Non-corticosteroid risk factors of symptomatic avascular necrosis of bone in systemic lupus erythematosus: A retrospective case-control study.Birmingham SLE cohort: outcomes of a large inception cohort followed for up to 21 years.Prevalence, incidence, and associated factors of avascular necrosis in Korean patients with systemic lupus erythematosus: a nationwide epidemiologic study.Previous antimalarial therapy in patients diagnosed with lupus nephritis: influence on outcomes and survival.Temporal course of avascular femoral head necrosis in patients with pemphigus vulgaris.The risk factors of avascular necrosis in patients with systemic lupus erythematosus: a meta-analysis.Osteonecrosis of the hip in Korean patients with systemic lupus erythematosus: risk factors and clinical outcome.Discrimination and Cumulative Disease Damage Among African American Women With Systemic Lupus Erythematosus.Symptomatic knee osteonecrosis in patients with systemic lupus erythematosus: a case–control study
P2860
Q33631028-103FAB8B-8CF5-4DD7-9984-42DA1AF02532Q33706654-46EF11A2-292B-4975-BD38-D80C923B1020Q34164223-4C997D49-5DF3-487D-A155-B8182BDC3DD4Q36165091-66D71F69-E011-4239-9DD6-F086F4361D5BQ36820668-65340919-0972-42EC-AB9C-6D03CA7BD545Q37108645-F771FB00-CA1A-4ED2-B518-43C48991267CQ37947108-1080AC12-6F74-4DD1-B2EB-917A04C338FBQ38011226-7AEB1674-6ED3-4F21-BA2C-8E31CD622F66Q39199424-46301628-E2B6-40DC-996F-41F22A1A8CC6Q39283399-A840DB82-1ED9-49A7-88EF-343A4D99929CQ41346610-3958A63B-C9EA-4DE5-94DD-E953C28B5732Q41663457-B5C8AD0E-5252-4F92-B4C7-337FB5430609Q41698087-193CBBB3-3FBA-4618-A7D3-20B7FF10300CQ41919918-BD2D5FD8-0BE0-41EC-A07C-43C63421B1F8Q41941085-491A875F-6D56-4F26-AE87-DC3B1CFC70F5Q51757617-0DBA6620-68DA-4F84-9B16-262BDB6F88DAQ53145049-AE0EFC50-3586-4AB9-9AAE-1C67D4D7E5D8Q53304418-56EBE256-5375-4E03-8307-D366A3E6FDD7Q53791872-7C451FC0-D6C3-46B7-8970-AC17C4D4FE17Q57603185-A98464C0-FBAB-4883-B17A-67398C769602
P2860
Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXIV. Cytotoxic treatment is an additional risk factor for the development of symptomatic osteonecrosis in lupus patients: results of a nested matched case-control study.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Systemic lupus erythematosus i ...... ed matched case-control study.
@ast
Systemic lupus erythematosus i ...... ed matched case-control study.
@en
type
label
Systemic lupus erythematosus i ...... ed matched case-control study.
@ast
Systemic lupus erythematosus i ...... ed matched case-control study.
@en
prefLabel
Systemic lupus erythematosus i ...... ed matched case-control study.
@ast
Systemic lupus erythematosus i ...... ed matched case-control study.
@en
P2093
P2860
P356
P1476
Systemic lupus erythematosus i ...... ed matched case-control study.
@en
P2093
B A Baethge
B J Fessler
E B González
E J Cepeda
G S Alarcón
H M Bastian
J Calvo-Alén
J M Roseman
P2860
P304
P356
10.1136/ARD.2005.040428
P407
P577
2005-11-03T00:00:00Z